GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 29 filers reported holding GEMPHIRE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $10,000 | 0.0% | 12,910 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $10,000 | -33.3% | 12,910 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $15,000 | +50.0% | 12,910 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | -63.0% | 12,910 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $27,000 | -72.4% | 12,910 | 0.0% | 0.00% | -71.4% |
| Q2 2018 | $98,000 | +16.7% | 12,910 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $84,000 | -18.4% | 12,910 | 0.0% | 0.01% | -22.2% |
| Q4 2017 | $103,000 | -16.3% | 12,910 | 0.0% | 0.01% | -35.7% |
| Q3 2017 | $123,000 | -11.5% | 12,910 | +18.8% | 0.01% | -22.2% |
| Q2 2017 | $139,000 | – | 10,870 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|